Psilocybin and Self-Awareness Study
Treatments studied
This trial tests whether a single dose of psilocybin (a psychedelic substance) can change self-awareness in healthy adults. It aims to understand how this substance affects the brain, which might lead to new mental health treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 21 and 60 years old.
- You need at least 8 years of formal schooling.
- You must speak Portuguese fluently.
- You must be willing to stop using recreational drugs, herbal supplements, and certain medications for one week before the study session.
- You must avoid caffeine and alcohol for 24 hours before the session, and avoid caffeine and nicotine for a few hours after.
- You cannot have a history of serious mental illness (like schizophrenia or bipolar disorder) or certain medical conditions (heart, brain, liver, or stomach diseases).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a single dose of psilocybin (a psychedelic compound) can help people update their beliefs and gain new insights. It's for healthy adults with some prior psychedelic experience, and it's a small pilot study at Brown University.
This study tests whether combining mindfulness training with a single dose of psilocybin (a psychedelic found in certain mushrooms) can help healthy adults. It aims to explore how these two approaches together might improve well-being.
This Phase 1/2 study tests psilocybin to see how it affects brain signals and the “content” of thoughts while you are monitored during the study. Because participants must be generally healthy and mentally stable, it may be an option if you meet those safety and medication rules and are comfortable having your brain activity measured.
This study tests how psilocybin, a psychedelic substance, affects the brain and body in healthy volunteers. It aims to find biological and mental changes that could help future therapies.
This trial tests how the setting and context affect the experience of psilocybin, a psychedelic drug. It aims to understand how the environment influences the effects in healthy adults.
This study looks at how psilocybin affects people's subjective experience. It aims to understand the mind-altering effects of this psychedelic compound in healthy volunteers.
Hear when a new Healthy Adults trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.